DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

NITTAGELA vs SUDARSHAN: Stock Comparison

NITTA GELATIN INDIA vs SUDARSHAN PHARMA INDUpdated 13 Nov 26, 4:08 PM ISTNSE & company filings

NITTA GELATIN INDIA shows a lower P/E, a higher dividend yield and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

NITTAGELA leads 5; SUDARSHAN leads 2 of 9

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

NITTAGELASUDARSHAN

Valuation lens

What price are you paying?

Market CapContext only
₹1,587 Cr
₹0 Cr
P/E RatioNITTAGELA has the lower reading
16.15x ✓
28.27x
P/B RatioNITTAGELA has the lower reading
3.1x ✓
4.11x
EPSNITTAGELA has the higher reading
₹27.73 ✓
₹0.32
Book ValueContext only
₹567.76
₹6.14
Dividend YieldNITTAGELA has the higher reading
0.4% ✓
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

P/E Ratio
NITTAGELA has a lower P/E
16.15x vs 28.27x
P/B Ratio
NITTAGELA has a lower P/B
3.1x vs 4.11x
EPS
NITTAGELA has higher earnings per share
₹27.73 vs ₹0.32
Dividend Yield
NITTAGELA has a higher dividend yield
0.4% vs 0%
Qtr Sales Growth
SUDARSHAN has stronger quarterly sales growth
24.4% vs 0%
Qtr Profit Growth
SUDARSHAN has stronger quarterly profit growth
38.7% vs 0%
Net Margin
NITTAGELA has a higher net margin
16.7% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricNITTAGELASUDARSHAN
Live Price₹1,733₹32.71
Day Change-3.15%0.03%
Volume3,19292,985
52-Week High₹2,087.2₹39.3
52-Week Low₹837.05₹31.01
Distance from 52W High-16.97%-16.77%

Valuation

MetricNITTAGELASUDARSHAN
Market Cap₹1,587 Cr₹0 Cr
P/E Ratio16.15x28.27x
P/B Ratio3.1x4.11x
EPS₹27.73₹0.32
Book Value₹567.76₹6.14
Dividend Yield0.4%0%

Growth

MetricNITTAGELASUDARSHAN
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%24.4%
Qtr Profit Growth0%38.7%

Profitability & Leverage

MetricNITTAGELASUDARSHAN
ROE19.06%—
ROCE19.53%—
Net Margin16.7%0%
Operating Margin22.8%—
Debt to Equity0.01x—

Shareholding

As of Jun 2026 • change vs previous quarter
MetricNITTAGELASUDARSHAN
Promoter Holding31.53%57.81%▼ 1.12 pp
FII Holding0.05%▲ 0.05 pp21.95%▲ 2.57 pp
DII Holding0.95%▲ 0.03 pp0%
Public Holding24.52%▼ 0.07 pp20.19%▼ 1.45 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: NITTA GELATIN INDIA and SUDARSHAN PHARMA IND.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.